authors
- Theman, Todd A
- Hartzell, Tristan L
- Indranil Sinha, MD
- Polson, Kathleen
- Morgan, Jeffrey
- Demetri, George D
- Orgill, Dennis P
- George, Suzanne
Recognition of a new chemotherapeutic vesicant: trabectedin (ecteinascidin-743) extravasation with skin and soft tissue damage.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2009
published in
has subject area
- Aged, 80 and over
- Antineoplastic Agents, Alkylating
- Catheterization, Central Venous
- Device Removal
- Dioxoles
- Drainage
- Extravasation of Diagnostic and Therapeutic Materials
- Female
- Follow-Up Studies
- Humans
- Immunohistochemistry
- Infusions, Intravenous
- Irritants
- Leiomyosarcoma
- Necrosis
- Severity of Illness Index
- Skin Ulcer
- Soft Tissue Injuries
- Tetrahydroisoquinolines
- Trabectedin
- Treatment Outcome